Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination scheduleAVDICOVA, Maria; PRIKAZSKY, Viktor; HUDECKOVA, Henrieta et al.European journal of pediatrics. 2002, Vol 161, Num 11, pp 581-587, issn 0340-6199, 7 p.Article

Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamolPRYMULA, Roman; HABIB, Ahsan; FRANCOIS, Nancy et al.Vaccine. 2013, Vol 31, Num 16, pp 2080-2088, issn 0264-410X, 9 p.Article

Prevention of otitis media: Now a reality?SCHUERMAN, Lode; BORYS, Dorota; HOET, Bernard et al.Vaccine. 2009, Vol 27, Num 42, pp 5748-5754, issn 0264-410X, 7 p.Article

Kinetics of the immune response following pneumococcal PD conjugate vaccinationSCHUERMAN, Lode; PRYMULA, Roman; CHROBOK, Viktor et al.Vaccine. 2007, Vol 25, Num 11, pp 1953-1961, issn 0264-410X, 9 p.Article

Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of agePRYMULA, Roman; KRIZ, Pavla; KALISKOVA, Eva et al.Vaccine. 2010, Vol 28, Num 1, pp 71-78, issn 0264-410X, 8 p.Article

Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccinesPRYMULA, Roman; CHLIBEK, Roman; SPLINO, Miroslav et al.Vaccine. 2008, Vol 26, Num 35, pp 4563-4570, issn 0264-410X, 8 p.Article

Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine : Immunogenicity 5 years post-vaccinationMCINTYRE, Peter B; BURGESS, Margaret A; EGAN, Annemarie et al.Vaccine. 2009, Vol 27, Num 7, pp 1062-1066, issn 0264-410X, 5 p.Article

Immunogenicity and reactogenicity of DTPa-HBY-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infantsVAZQUEZ, Liliana; GARCIA, Fabiana; RÜTTIMANN, Ricardo et al.Acta paediatrica (Oslo). 2008, Vol 97, Num 9, pp 1243-1249, issn 0803-5253, 7 p.Article

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adultsGRIMPREL, Emmanuel; VON SONNENBURG, Frank; SÄNGER, Roland et al.Vaccine. 2005, Vol 23, Num 28, pp 3657-3667, issn 0264-410X, 11 p.Article

Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in InfantsKNUF, Markus; SCHMITT, Heinz-Joesf; WOLTER, Joanne et al.The Journal of pediatrics. 2008, Vol 152, Num 5, pp 655-660, issn 0022-3476, 6 p.Article

Immunity to Pertussis 5 Years after Booster Immunization during Adolescence. CommentaryEDELMAN, Kati; QIUSHUI HE; MÄKINEN, Johanna et al.Clinical infectious diseases. 2007, Vol 44, Num 10, pp 1271-1279, issn 1058-4838, 9 p.Article

Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and haemophilus influenzae type B vaccine : A randomized dose-ranging trial of the hib tetanus-conjugate contentKHIN HLA HLA; SAW AUNG MYAT THEIN; AYE, Aye et al.The Pediatric infectious disease journal. 2006, Vol 25, Num 8, pp 706-712, issn 0891-3668, 7 p.Article

Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus Influenzae type b conjugate vaccinePICHICHERO, Michael E; BERNSTEIN, Henry; BLATTER, Mark M et al.The Journal of pediatrics. 2007, Vol 151, Num 1, pp 43-49, issn 0022-3476, 7 p.Article

Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)KNUF, Markus; SZENBORN, Leszek; MORO, Masnuel et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 4, issn 0891-3668, S97-S108, SUPArticle

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trialPALMU, Arto A; JOKINEN, Jukka; SCHUERMAN, Lode et al.Lancet (British edition). 2013, Vol 381, Num 9862, pp 214-222, issn 0140-6736, 9 p.Article

Antibody persistence after primary vaccination with a hexavalent DTPa-HBV-IPV/HIB vaccine coadministered with a meningococcal C-CRM₁₉₇ vaccine and response to a DTPa-IPV/HIB booster at 18 months of ageTEJEDOR, Juan-Carlos; OMENACA, Félix; ENRUBIA, Manuel et al.The Pediatric infectious disease journal. 2006, Vol 25, Num 10, pp 943-945, issn 0891-3668, 3 p.Article

Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccinePARTRIDGE, Susan; ALVEY, Justin; BERNSTEIN, Henry et al.Vaccine. 2007, Vol 25, Num 10, pp 1806-1813, issn 0264-410X, 8 p.Article

Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 monthsTEJEDOR, Juan C; MORO, Manuel; JURADO, Antonio et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 1, pp 1-7, issn 0891-3668, 7 p.Article

Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccineTEJEDOR, Juan C; MORO, Manuel; JURADO, Antonio et al.The Pediatric infectious disease journal. 2006, Vol 25, Num 8, pp 713-720, issn 0891-3668, 8 p.Article

Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccineTEJEDOR, Juan C; OMENACA, Félix; MORAGA, Fernando et al.The Pediatric infectious disease journal. 2004, Vol 23, Num 12, pp 1109-1115, issn 0891-3668, 7 p.Article

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM VaccineVESIKARI, Timo; WYSOCKI, Jacek; CHEVALLIER, Bertrand et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 4, issn 0891-3668, S66-S76, SUPArticle

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate VaccinesWYSOCKI, Jacek; TEJEDOR, Juan C; GRUNERT, Dutlef et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 4, issn 0891-3668, S77-S88, SUPArticle

Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood VaccinesCHEVALLIER, Bertrand; VESIKARI, Timo; BRZOSTEK, Jerzy et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 4, issn 0891-3668, S109-S118, SUPArticle

Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV combination vaccine Co-administered with a Hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of ageGABUTTI, Giovanni; ZEPP, Fred; SCHUERMAN, Lode et al.Scandinavian journal of infectious diseases. 2004, Vol 36, Num 8, pp 585-592, issn 0036-5548, 8 p.Article